Show source-provided references
1. Fontana, F., Anselmi, M., and Limonta, P. (2022). Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression. Cancers, 14.
10.3390/cancers14071614 ↗3. Ursolic Acid Enhances the Therapeutic Effects of Oxaliplatin in Colorectal Cancer by Inhibition of Drug Resistance
10.1111/cas.13425 ↗5. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
10.3322/caac.21660 ↗6. Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci., 21.
10.3390/ijms21093233 ↗8. Roszczenko, P., Holota, S., Szewczyk, O.K., Dudchak, R., Bielawski, K., Bielawska, A., and Lesyk, R. (2022). 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. Int. J. Mol. Sci., 23.
10.3390/ijms232113135 ↗11. Skóra, B., Lewińska, A., Kryshchyshyn-Dylevych, A., Kaminskyy, D., Lesyk, R., and Szychowski, K.A. (2022). Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives. Molecules, 27.
10.3390/molecules27030894 ↗13. PPARγ Activation by Thiazolidinediones (TZDs) May Modulate Breast Carcinoma Outcome: The Importance of Interplay with TGFβ Signalling
10.1111/j.1582-4934.2007.00003.x ↗15. Augimeri, G., and Bonofiglio, D. (2021). PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy. Biomedicines, 9.
10.3390/biomedicines9050543 ↗17. Anticancer Properties of 4-Thiazolidinone Derivatives Depend on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
10.1016/j.ejmech.2017.09.071 ↗18. The Aryl Hydrocarbon Receptor: An Environmental Sensor Integrating Immune Responses in Health and Disease
10.1038/s41577-019-0125-8 ↗19. Guarnieri, T. (2020). Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer. Int. J. Mol. Sci., 21.
10.3390/ijms21155264 ↗20. Huang, Y., He, J., Liang, H., Hu, K., Jiang, S., Yang, L., Mei, S., Zhu, X., Yu, J., and Kijlstra, A. (2018). Aryl Hydrocarbon Receptor Regulates Apoptosis and Inflammation in a Murine Model of Experimental Autoimmune Uveitis. Front. Immunol., 9.
10.3389/fimmu.2018.01713 ↗23. The RelA NF-KappaB Subunit and the Aryl Hydrocarbon Receptor (AhR) Cooperate to Transactivate the c-Myc Promoter in Mammary Cells
10.1038/sj.onc.1203945 ↗25. Microarray Analysis of Gene Expression in Metastatic Gastric Cancer Cells after Incubation with the Methylation Inhibitor 5-Aza-2’-Deoxycytidine
10.1007/s10585-005-1043-7 ↗26. Wang, Z., Snyder, M., Kenison, J.E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A., and Monti, S. (2021). How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression. Int. J. Mol. Sci., 22.
10.3390/ijms22010387 ↗27. Aryl Hydrocarbon Receptor (AhR) Regulates Adipocyte Differentiation by Assembling CRL4B Ubiquitin Ligase to Target PPARγ for Proteasomal Degradation
10.1074/jbc.RA119.009282 ↗31. Identification and Inhibition of the ICE/CED-3 Protease Necessary for Mammalian Apoptosis
10.1038/376037a0 ↗32. Epidermal Growth Factor-Labeled Liposomes as a Way to Target the Toxicity of Silver Nanoparticles into EGFR-Overexpressing Cancer Cells in Vitro
10.1016/j.taap.2022.116009 ↗33. Szychowski, K.A., Skóra, B., Kryshchyshyn-Dylevych, A., Kaminskyy, D., Khyluk, D., and Lesyk, R. (2021). 4-Thiazolidinone-Based Derivatives Rosiglitazone and Pioglitazone Affect the Expression of Antioxidant Enzymes in Different Human Cell Lines. Biomed. Pharmacother., 139.
10.1016/j.biopha.2021.111684 ↗34. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
10.1016/0003-2697(76)90527-3 ↗35. Finiuk, N., Kaleniuk, E., Holota, S., Stoika, R., Lesyk, R., and Szychowski, K.A. (2023). Pyrrolidinedione-Thiazolidinone Hybrid Molecules with Potent Cytotoxic Effect in Squamous Cell Carcinoma SCC-15 Cells. Bioorganic Med. Chem., 92.
10.1016/j.bmc.2023.117442 ↗37. Yamamoto, K., Tamura, T., Nakamura, R., Hosoe, S., Matsubara, M., Nagata, K., Kodaira, H., Uemori, T., Takahashi, Y., and Suzuki, M. (2019). Development of a Novel Class of Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligands as an Anticancer Agent with a Unique Binding Mode Based on a Non-Thiazolidinedione Scaffold. Bioorg. Med. Chem., 27.
10.1016/j.bmc.2019.115122 ↗40. The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological Activities
10.1124/mol.107.041202 ↗41. 4-Thiazolidinone Derivative Les-3833 Effectively Inhibits Viability of Human Melanoma Cells through Activating Apoptotic Mechanisms
10.3325/cmj.2017.58.129 ↗42. Implication of Intracellular ROS Formation, Caspase-3 Activation and Egr-1 Induction in Platycodon D-Induced Apoptosis of U937 Human Leukemia Cells
10.1016/j.biopha.2008.08.001 ↗44. Eskandari, E., and Eaves, C.J. (2022). Paradoxical Roles of Caspase-3 in Regulating Cell Survival, Proliferation, and Tumorigenesis. J. Cell Biol., 221.
10.1083/jcb.202201159 ↗45. Differential Pro-Apoptotic Effects of Synthetic 4-Thiazolidinone Derivative Les-3288, Doxorubicin and Temozolomide in Human Glioma U251 Cells
10.3325/cmj.2017.58.150 ↗48. Grishanova, A.Y., and Perepechaeva, M.L. (2022). Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance. Int. J. Mol. Sci., 23.
10.3390/ijms23126719 ↗49. Kosińska, K., Skóra, B., Holota, S., Shepeta, Y., Tabęcka-Łonczyńska, A., Lesyk, R., and Szychowski, K.A. (2024). Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines. Cells, 13.
10.3390/cells13121007 ↗50. 4-Thiazolidinone-Based Derivatives Do Not Affect Differentiation of Mouse Embryo Fibroblasts (3T3-L1 Cell Line) into Adipocytes
10.1016/j.cbi.2021.109538 ↗51. Szlachcikowska, D., Tabęcka-Łonczyńska, A., Holota, S., Roman, O., Shepeta, Y., Lesyk, R., and Szychowski, K.A. (2024). Role of Ciminalum-4-Thiazolidinone Hybrids in Molecular NF-ΚB Dependent Pathways. Int. J. Mol. Sci., 25.
10.3390/ijms25137329 ↗53. Ciglitazone Induces Early Cellular Proliferation and NF-ΚB Transcriptional Activity in Colon Cancer Cells through P65 Phosphorylation
10.1016/j.biocel.2004.08.008 ↗54. Rosiglitazone Alleviates Lipopolysaccharide-Induced Inflammation in RAW264.7 Cells via Inhibition of NF-ΚB and in a PPARγ-Dependent Manner
55. Insights into the Critical Role of the PXR in Preventing Carcinogenesis and Chemotherapeutic Drug Resistance
10.7150/ijbs.68724 ↗56. Mutual Repression between Steroid and Xenobiotic Receptor and NF-KappaB Signaling Pathways Links Xenobiotic Metabolism and Inflammation
10.1172/JCI26283 ↗